The therapeutic effect of GLP-1 on MASH is thought to be due to a reduction in body weight caused by a decrease in appetite and insulin resistance, which leads to an improvement in dyslipidemia and hepatic inflammation 33,34
How large an impact are new weight loss drugs having on patients and medical providers
Most users notice clear efficacy changes once they reach 8mg or above
For instance, GLP-1 treatment can be expensive, and insurance coverage may be limited
Naomi Parrella, the chief of lifestyle medicine and the medical director for the Weight Loss and Lifestyle Medicine Clinics at Rush University in Illinois
Shah P, Ardestani A, Dharmadhikari G, Laue S, Schumann DM, Kerr-Conte J, et al